BICO Group
35.86
SEK
-5.13 %
Less than 1K followers
BICO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
-5.13%
-10.97%
+16.66%
+11.99%
-10.35%
-15.46%
-80.21%
-61.81%
+163.19%
BICO Group operates in the biotechnology industry and focuses on the development and manufacturing of technologies for cell-based research and medical development. The company's products are aimed at researchers and pharmaceutical companies. The business is global with a main presence in Europe, North America and Asia. BICO Group was founded in 2016 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
2.53B SEK
Turnover
7.15M SEK
Revenue
1.95B
EBIT %
-14.85 %
P/E
-
Dividend yield-%
-
Financial calendar
29/4
2025
Interim report Q1'25
8/5
2025
General meeting '25
19/8
2025
Interim report Q2'25
All
Webcasts
Press releases
ShowingAll content types
Invitation to the presentation of BICO’s Interim report Q1 2025
Correction: Notice to attend Annual General Meeting in BICO Group AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Rättelse: Kallelse till Årsstämma i BICO Group AB (publ)
Kallelse till Årsstämma i BICO Group AB (publ)
Notice to attend Annual General Meeting in BICO Group AB (publ)
BICO har ingått ett avtal att avyttra MatTek till Sartorius för 80 MUSD
BICO has entered into an agreement to divest MatTek to Sartorius for USD 80m

BICO, Audiocast with teleconference, Q1'25
BICO publicerar års- och hållbarhetsredovisning 2024
BICO Publishes Annual and Sustainability Report 2024
